Pfizer Limited (NSE:PFIZER)
India · Delayed Price · Currency is INR 5,318.00
+48.50 (0.92%)
Oct 30, 2025, 3:29 PM IST
Pfizer Revenue
Pfizer had revenue of 6.03B INR in the quarter ending June 30, 2025, with 7.14% growth. This brings the company's revenue in the last twelve months to 23.22B, up 4.35% year-over-year. In the fiscal year ending March 31, 2025, Pfizer had annual revenue of 22.81B with 4.02% growth.
Revenue (ttm)
23.22B
Revenue Growth
+4.35%
P/S Ratio
10.48
Revenue / Employee
14.53M
Employees
1,598
Market Cap
243.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 22.81B | 881.80M | 4.02% |
| Mar 31, 2024 | 21.93B | -2.32B | -9.55% |
| Mar 31, 2023 | 24.25B | -1.86B | -7.13% |
| Mar 31, 2022 | 26.11B | 3.71B | 16.54% |
| Mar 31, 2021 | 22.40B | 887.20M | 4.12% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 274.80B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |
Pfizer News
- 2 months ago - Pfizer shares jump over 5% as Q1 net profit surges 27.2% YoY - Business Upturn
- 2 months ago - Pfizer shares jump over 2% after launch of next-gen 20-valent pneumococcal vaccine in India - Business Upturn